Most Read Articles
6 days ago

Dr Michael Lim, a senior consultant at the Paediatric Pulmonary and Sleep Division, National University Hospital, Singapore, speaks to Roshini Claire Anthony on the rare disease that is cystic fibrosis.

4 days ago
Susceptibility‐guided therapy is as effective as empiric modified bismuth quadruple therapy for the first-line treatment of Helicobacter pylori infection, with both yielding excellent eradication rates, as shown in a recent trial.
6 days ago
It appears that long-term consumption of fish and omega-3 fatty acid does not influence the risk of incident hypertension in middle-aged and older men, suggests a US study.
2 days ago
Cabozantinib is not better than mitoxantrone-prednisone at relieving pain in patients with metastatic castration-resistant prostate cancer (mCRPC) with symptomatic bone metastasis, a recent study suggests.

Surgical treatment of adolescent gynaecomastia improves quality of life

24 Nov 2018

Surgical treatment of gynaecomastia in adolescents improves quality of life (QoL), as well as physical and psychosocial functioning, a recent study has shown.

Through surveys administered to adolescents with gynaecomastia (n=44; mean age 16.5±1.9 years) and male controls (n=64; mean age 15.9±2.3 years), researchers measured participant QoL. The Short-From 36 (SF-36) version 2, Rosenberg Self-Esteem Scale (RSES) and Eating Attitudes Test-26 (EAT-26) surveys were employed postoperatively and at 6 months, 1 year, 3 years and 5 years of follow-up.

At baseline, patients had significantly lower scores than controls in the SF-36 domains of general health (p<0.001), vitality (p<0.001), social functioning (p<0.001), role-emotional (p=0.008), mental health (p=0.002) and RSES (p<0.001), and higher scores in the EAT-26 survey (p<0.001).

At the 6-month follow-up, only scores in the bodily pain (p=0.04) and general health (p=0.02) SF-36 domains, as well as in the RSES (p=0.003) and EAT-26 (p<0.001) surveys were significantly different between patients and controls. By 5 years, only EAT-26 scores were significantly different (p=0.02).

Gynaecomastia patients showed significant improvements in five SF-36 domains after surgery (physical functioning: difference, 10.8; p=0.002; role-physical: difference, 8.5; p=0.009; bodily pain: difference, 7.4; p=0.01; general health: difference, 5.2; p=0.04; social functioning: difference, 17.7; p=0.001).

In comparison, the preoperative-to-postoperative change in RSES score only approached significance (difference, 2.0; p=0.05), while EAT-26 scores did not significantly change (difference, –0.3; p=0.79).

Controls did not show significant changes in any of the survey scores from baseline to follow-up (p>0.05 for all).

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
6 days ago

Dr Michael Lim, a senior consultant at the Paediatric Pulmonary and Sleep Division, National University Hospital, Singapore, speaks to Roshini Claire Anthony on the rare disease that is cystic fibrosis.

4 days ago
Susceptibility‐guided therapy is as effective as empiric modified bismuth quadruple therapy for the first-line treatment of Helicobacter pylori infection, with both yielding excellent eradication rates, as shown in a recent trial.
6 days ago
It appears that long-term consumption of fish and omega-3 fatty acid does not influence the risk of incident hypertension in middle-aged and older men, suggests a US study.
2 days ago
Cabozantinib is not better than mitoxantrone-prednisone at relieving pain in patients with metastatic castration-resistant prostate cancer (mCRPC) with symptomatic bone metastasis, a recent study suggests.